Clinical Trial Update: Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a phase 1/2 study of everolimus plus docetaxel in recurrent, locally advanced, or metastatic head and neck cancer; the trial status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Afinitor (everolimus)
• Taxotere (docetaxel)

Snippet

Sponsor: University College, London | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: TERMINATED